Author

I. Gonzalez-Dominguez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Assay:proteomics· 2 Organism:human· 1 Organism:non-human primate· 1 Organism:rat· 1

Frequent Co-Authors

F. Krammer· 3 shared W. Sun· 3 shared A. Garcia-Sastre· 2 shared F. Amanat· 2 shared G. Singh· 2 shared I. Mena· 2 shared J. M. Carreno· 2 shared L. Coughlan· 2 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

F. Krammer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination

J. Clark, I. Hoxie, D. Adelsberg, I. Sapse, R. Andreata-Santos, J. Yong, F. Amanat, J. Tcheou, A. Raskin, G. Singh, I. Gonzalez-Dominguez, J. Edgar, S. Bournazos, W. Sun, J. M. Carreno, , F. Krammer

This study identifies non-neutralizing antibodies from vaccinated individuals that protect against SARS-CoV-2 in animal models, highlighting their role through Fc-mediated effector functions and conserved epitope binding.

bioRxiv · Feb 28, 2024Immunology

Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice

I. Gonzalez-Dominguez, J. L. Martinez, S. Slamanig, N. Lemus, Y. Liu, T. Y. Lai, J. M. Carreno, G. Singh, G. Singh, M. Schotsaert, I. Mena, S. McCroskery, L. Coughlan, F. Krammer, A. Garcia-Sastre, , W. Sun

The paper tests a trivalent NDV-HXP-S vaccine against SARS-CoV-2 variants in mice, showing increased protection and cross-neutralizing antibodies against Omicron.

bioRxiv · Mar 21, 2022Immunology

A Newcastle disease virus-vector expressing a prefusion-stabilized spike protein of SARS-CoV-2 induces protective immune responses against prototype virus and variants of concern in mice and hamsters

W. Sun, Y. Liu, F. Amanat, I. Gonzalez-Dominguez, S. McCroskery, S. Slamanig, L. Coughlan, V. Rosado, N. Lemus, S. Jangra, R. Rathnasinghe, M. Schotsaert, J. Martinez, K. Sano, I. Mena, , P. Palese

This study develops a Newcastle disease virus-based vaccine expressing a prefusion-stabilized SARS-CoV-2 spike protein, showing strong immune responses and cross-neutralization against variants in mice and hamsters.

bioRxiv · Jul 6, 2021 · PreprintImmunology